Postbiotics are known to suppress inflammatory markers, such as IL-1 and IL-6, support the structure of the stratum corneum through the action of short-chain fatty acids, and improve outcomes in inflammatory skin conditions, including atopic dermatitis, eczema, and acne [45,55,56,57]. The gene discussed is IL6; the disease is atopic eczema.